Corrigendum to “A phase 2 study of tislelizumab in combination with platinum-based chemotherapy as first-line treatment for advanced lung cancer in Chinese patients” [Lung Cancer 147 (2020) 259–268]
Titel:
Corrigendum to “A phase 2 study of tislelizumab in combination with platinum-based chemotherapy as first-line treatment for advanced lung cancer in Chinese patients” [Lung Cancer 147 (2020) 259–268]
Auteur:
Wang, Zhijie Zhao, Jun Ma, Zhiyong Cui, Jiuwei Shu, Yongqian Liu, Zhe Cheng, Ying Leaw, Shiang J. Wu, Yanjie Ma, Yan Tan, Wei Ma, Xiaopeng Zhang, Yun Wang, Jie